LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

APL

BSE
ASSTON PHARMACEUTICALS LIMITED
· INE0SJX01015· Scrip: 544445
ENहिन्दीગુજરાતીमराठी
75.40
8.60 (+0.00%)
2026-04-16
BSE
75.40
8.60
+0.00%
68829711112607-1608-2510-0111-1312-3002-0904-1304-16
159 trading days · 1Y period
TODAY (BSE)
Open84.00
High84.00
Low73.01
Prev Close84.00
Volume40,000
Value₹0.3Cr
L: 73.01H: 84.00
Info
ISININE0SJX01015
SeriesM
BSE Scrip544445

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
PAT
EPS

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr4 Cr8 Cr12 Cr15 Cr25-09
QuarterRevenueExpensesEBITDAPBTPATEPS
2025-09-3015 Cr14 Cr0 Cr0.05

Price History

DateOpenHighLowCloseVolume
2026-04-1684.0084.0073.0175.4040,000
2026-04-1588.0088.0083.3584.005,000
2026-04-1386.9095.6585.0088.009,000
2026-04-0987.2987.2987.2987.291,000
2026-04-0675.1576.0175.0076.014,000
2026-03-3069.0073.0065.2073.0014,000
2026-03-2769.0071.0068.5070.3823,000
2026-03-2573.9075.0070.0070.0010,000
2026-03-2475.5075.5070.0070.0013,000
2026-03-2369.0072.0068.0068.1811,000
2026-03-2077.5077.5070.1070.159,000
2026-03-1973.0073.0072.5072.509,000
2026-03-1774.0074.0074.0074.002,000
2026-03-1370.2676.0070.2675.008,000
2026-03-1079.0082.0079.0082.003,000
2026-03-0978.0078.0078.0078.004,000
2026-03-0681.0081.0080.5080.504,000
2026-03-0578.0080.5078.0079.252,000
2026-03-0479.0080.0075.2475.6312,000
2026-02-2580.0082.0080.0082.0025,000
2026-02-2080.1083.0080.1082.008,000
2026-02-1982.8083.0080.0082.7119,000
2026-02-1876.5082.0076.5082.006,000
2026-02-1782.0082.0080.6080.906,000
2026-02-1680.0182.0080.0182.007,000
2026-02-1287.0087.0081.8081.955,000
2026-02-1186.0086.0080.5081.8013,000
2026-02-1079.0581.0079.0581.003,000
2026-02-0978.6378.6378.6378.631,000
2026-02-0680.0083.0080.0081.345,000

Frequently Asked Questions

About

Asston Pharmaceuticals Limited, listed on the BSE as APL, is an Indian company engaged in the manufacturing and export of pharmaceutical formulations and nutraceutical products, serving domestic and African markets. The company's key offerings include a range of generic and branded medicines, alongside health supplements, positioning it as a notable player in the pharmaceutical sector with a focus on accessibility and international reach.